Novartis to Buy UK Biotech Myricx for Up to $1.5 Billion, Boosting ADC Portfolio
Novartis is significantly expanding its oncology portfolio after securing an antibody-drug conjugate technology designed to deliver potent anticancer...
Search results for "new drug development"
Qurient’s Mocaciclib Opens New Combination Frontiers for Hard-to-Treat Breast Cancer
Qurient announced on June 29 that it presented key clinical data highlighting the mechanistic advantages of its CDK7-inhibiting oncology candidate,...
For Cancer Caregivers, the Dread of Future Costs Harms Health 8 Times More Than Actual Bills
For many families navigating a parent or loved one’s cancer diagnosis, sleepless nights become the new normal.
Air Pollution Threatens Skin Health: Fine Dust Increases Psoriasis Risk by Up to 27%
A large-scale study has found that fine dust can severely damage skin health, expanding the known dangers of air...
Diabetes Drug Repurposed: Evogliptin Shows Promise in Preventing Disfiguring Burn Scars
Burn survivors frequently face a distressing secondary complication known as hypertrophic scarring, where the skin...
From Bludgeon to Scalpel: ASCO 2026 Signals Oncology’s Shift From ‘Strong Chemo’ to ‘Right Chemo’
The standard of care in cancer treatment is undergoing a rapid paradigm shift. For decades, the default oncological...
MSD Bets $510M on High-Quality Data to Fuel Post-Keytruda AI Drug Discovery
MSD, which has long dominated the global cancer market with its blockbuster immuno-oncology therapy Keytruda, is...
New Hope for MASH: Researchers Uncover Key to Reversing Liver Fibrosis
Researchers have unveiled findings that raise hopes for a future where a single pill could safely and effectively treat...
Curocell’s Homegrown CAR-T Therapy Rimqarto Lands Spotlight in Top Hematology Journal Blood
Curocell, a South Korean clinical-stage biotech company specializing in chimeric antigen receptor T-cell (CAR-T)...
Amyloid Is Not the Only Culprit: GRK2 Protein Emerges as New Target in Alzheimer’s Fight
For decades, Alzheimer’s disease research has focused intensely on two primary culprits: beta-amyloid, which forms...